Context Therapeutics Inc. (CNTX)

Context Therapeutics Statistics

Total Valuation

CNTX has a market cap or net worth of $106.58 million. The enterprise value is $29.78 million.

Market Cap	106.58M
Enterprise Value	29.78M

Important Dates

The last earnings date was Wednesday, November 5, 2025, after market close.

Earnings Date	Nov 5, 2025
Ex-Dividend Date	n/a

Share Statistics

CNTX has 91.88 million shares outstanding. The number of shares has increased by 119.13% in one year.

Current Share Class	91.88M
Shares Outstanding	91.88M
Shares Change (YoY)	+119.13%
Shares Change (QoQ)	-0.00%
Owned by Insiders (%)	1.36%
Owned by Institutions (%)	20.25%
Float	40.02M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	1.46
P/TBV Ratio	1.46
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 13.10, with a Debt / Equity ratio of 0.00.

Current Ratio	13.10
Quick Ratio	12.75
Debt / Equity	0.00
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -33.68% and return on invested capital (ROIC) is -23.99%.

Return on Equity (ROE)	-33.68%
Return on Assets (ROA)	-22.81%
Return on Invested Capital (ROIC)	-23.99%
Return on Capital Employed (ROCE)	-41.27%
Revenue Per Employee	n/a
Profits Per Employee	-$2.20M
Employee Count	12
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -41.12% in the last 52 weeks. The beta is 1.94, so CNTX's price volatility has been higher than the market average.

Beta (5Y)	1.94
52-Week Price Change	-41.12%
50-Day Moving Average	1.10
200-Day Moving Average	0.85
Relative Strength Index (RSI)	50.43
Average Volume (20 Days)	327,667

Short Selling Information

The latest short interest is 847,576, so 0.92% of the outstanding shares have been sold short.

Short Interest	847,576
Short Previous Month	465,787
Short % of Shares Out	0.92%
Short % of Float	2.12%
Short Ratio (days to cover)	1.71

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-30.21M
Pretax Income	-26.44M
Net Income	-26.44M
EBITDA	-30.19M
EBIT	-30.21M
Earnings Per Share (EPS)	-$0.29

Balance Sheet

The company has $76.94 million in cash and $140,200 in debt, giving a net cash position of $76.80 million or $0.84 per share.

Cash & Cash Equivalents	76.94M
Total Debt	140,200
Net Cash	76.80M
Net Cash Per Share	$0.84
Equity (Book Value)	73.17M
Book Value Per Share	0.80
Working Capital	73.02M

Cash Flow

In the last 12 months, operating cash flow was -$22.35 million and capital expenditures -$33,948, giving a free cash flow of -$22.38 million.

Operating Cash Flow	-22.35M
Capital Expenditures	-33,948
Free Cash Flow	-22.38M
FCF Per Share	-$0.24

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

CNTX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-119.13%
Shareholder Yield	-119.13%
Earnings Yield	-24.81%
FCF Yield	-21.00%

Analyst Forecast

The average price target for CNTX is $5.40, which is 365.52% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$5.40
Price Target Difference	365.52%
Analyst Consensus	Strong Buy
Analyst Count	7
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	-16.14%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1